Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease

被引:10
|
作者
Tan, Hui-Hui [1 ,5 ]
Fiel, M. Isabel [2 ]
Sun, Qinghua [3 ]
Guo, Jinsheng [1 ,6 ]
Gordon, Ronald E. [2 ]
Chen, Lung-Chi [4 ]
Friedman, Scott L. [1 ]
Odin, Joseph A. [1 ,4 ]
Allina, Jorge [1 ,4 ]
机构
[1] Mt Sinai Sch Med, Dept Med, New York, NY USA
[2] Mt Sinai Sch Med, Dept Pathol, New York, NY USA
[3] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA
[4] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA
[5] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore 0316, Singapore
[6] Fudan Univ, Zhongshan Hosp, Div Digest Dis, Shanghai 200433, Peoples R China
关键词
Toll-like receptor; kupffer cell; steatohepatitis; fibrosis; IL-6; OBSTRUCTIVE PULMONARY-DISEASE; DIESEL EXHAUST PARTICLES; TOLL-LIKE RECEPTOR-4; SUBCHRONIC EXPOSURES; POLLUTION PARTICLES; ENDOTHELIAL-CELLS; HEPATIC-FIBROSIS; OXIDATIVE STRESS; MICE; STEATOHEPATITIS;
D O I
10.3109/15476910903241704
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Owing to increased obesity, non-alcoholic fatty liver disease (NAFLD) is now the most prevalent liver disease in the United States. NAFLD is considered a component of metabolic syndrome, a cluster of disorders that also includes diabetes mellitus, dyslipidemia, arteriosclerosis, and hypertension. Exposure to ambient air particulate matter with aerodynamic diameters < 2.5 mu m (PM2.5) is a risk factor for arteriosclerosis and lung disease, but its effect on NAFLD is unknown. PM2.5 induces pulmonary dysfunction via Toll-like receptor (TLR) activation on alveolar macrophages. TLR activation of Kupffer cells, resident hepatic macrophages, and subsequent pro-inflammatory cytokine production have been shown to play a key role in NAFLD progression. We hypothesized that PM2.5 exposure is a significant risk factor for the progression of NAFLD. Thus, following exposure of male C57BL/6 mice fed high fat chow (HFC) to concentrated air particulate matter (CAPs) or filtered air for 6 weeks, progression of NAFLD was evaluated by standardized histological assessment of hepatic inflammation and fibrosis. In mice fed HFC, the hepatic inflammatory grade (3.00 +/- 0.00 vs. 1.50 +/- 0.71, P < 0.001) and fibrosis stage (1.00 +/- 0.00 vs. 0.60 +/- 0.52, P = 0.023) were both significantly higher in mice exposed to CAPs versus filtered air, respectively. Increased numbers of Kupffer cells contained PM in CAPs-exposed mice scores of (2.00 +/- 0.94 vs. 0.20 +/- 0.42, respectively, P < 0.001). PM exposure increased IL-6 secretion up to sevenfold in a dose-dependent manner by isolated wild-type but not TLR4(-/-) Kupffer cells (P < 0.050). In conclusion, ambient PM2.5 exposure may be a significant risk factor for NAFLD progression.
引用
收藏
页码:266 / 275
页数:10
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377
  • [22] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    [J]. JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [23] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    [J]. HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
  • [24] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [25] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    [J]. ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [26] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    [J]. LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [27] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    [J]. INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
  • [28] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    [J]. CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512
  • [29] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [30] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    [J]. OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467